Search Results - "Villa‐Morales, María"

Refine Results
  1. 1

    Targeting the Fas/FasL signaling pathway in cancer therapy by Villa-Morales, María, Fernández-Piqueras, José

    Published in Expert opinion on therapeutic targets (01-01-2012)
    “…The Fas/FasL system plays a significant role in tumorigenesis. Research has shown that its impairment in cancer cells may lead to apoptosis resistance and…”
    Get more information
    Journal Article
  2. 2

    The JAK3Q988P mutation reveals oncogenic potential and resistance to ruxolitinib by Lahera, Antonio, Vela‐Martín, Laura, Fernández‐Navarro, Pablo, Llamas, Pilar, López‐Lorenzo, José L., Cornago, Javier, Santos, Javier, Fernández‐Piqueras, José, VillaMorales, María

    Published in Molecular carcinogenesis (01-01-2024)
    “…T‐cell acute lymphoblastic leukemia (T‐ALL) arises from the malignant transformation of T‐cell progenitors at various differentiation stages. Given that…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Identification of NRF2 Activation as a Prognostic Biomarker in T-Cell Acute Lymphoblastic Leukaemia by Villa-Morales, María, Pérez-Gómez, Laura, Pérez-Gómez, Eduardo, López-Nieva, Pilar, Fernández-Navarro, Pablo, Santos, Javier

    “…The standard-of-care treatment of T-cell acute lymphoblastic leukaemia (T-ALL) with chemotherapy usually achieves reasonable rates of initial complete…”
    Get full text
    Journal Article
  5. 5

    A Dual Role for FADD in Human Precursor T-Cell Neoplasms by Marín-Rubio, José Luis, Vela-Martín, Laura, Gudgeon, Jack, Pérez-Gómez, Eduardo, Sidgwick, Frances R, Trost, Matthias, Cunningham, Debbie L, Santos, Javier, Fernández-Piqueras, José, Villa-Morales, María

    “…A reduction in levels has been reported in precursor T-cell neoplasms and other tumor types. Such reduction would impact on the ability of tumor cells to…”
    Get full text
    Journal Article
  6. 6

    PIM1 is a potential therapeutic target for the leukemogenic effects mediated by JAK/STAT pathway mutations in T-ALL/LBL by Lahera, Antonio, Vela-Martín, Laura, Fernández-Navarro, Pablo, Llamas, Pilar, López-Lorenzo, José L., Cornago, Javier, Santos, Javier, Fernández-Piqueras, José, Villa-Morales, María

    Published in NPJ precision oncology (20-07-2024)
    “…Precursor T-cell neoplasms (T-ALL/LBL) are aggressive hematological malignancies that arise from the malignant transformation of immature thymocytes. Despite…”
    Get full text
    Journal Article
  7. 7
  8. 8

    A Role for Endoglin as a Suppressor of Malignancy during Mouse Skin Carcinogenesis by PEREZ-GOMEZ, Eduardo, VILLA-MORALES, Maria, SANTOS, Javier, FERNANDEZ-PIQUERAS, José, GAMALLO, Carlos, DOTOR, Javier, BERNABEU, Carmelo, QUINTANILLA, Miguel

    Published in Cancer research (Chicago, Ill.) (01-11-2007)
    “…Endoglin is a membrane glycoprotein that acts as a coreceptor for transforming growth factor-beta. We and others have previously suggested a function of…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    S194-P-FADD as a marker of aggressiveness and poor prognosis in human T-cell lymphoblastic lymphoma by Marín-Rubio, José L, Pérez-Gómez, Eduardo, Fernández-Piqueras, José, Villa-Morales, María

    Published in Carcinogenesis (New York) (16-10-2019)
    “…Abstract T-cell lymphoblastic lymphoma is a haematological disease with an urgent need for reliable prognostic biomarkers that allow therapeutic stratification…”
    Get full text
    Journal Article
  12. 12
  13. 13

    A role for the Fas/FasL system in modulating genetic susceptibility to T-cell lymphoblastic lymphomas by VILLA-MORALES, Maria, SANTOS, Javier, PEREZ-GOMEZ, Eduardo, QUINTANILLA, Miguel, FERNANDEZ-PIQUERAS, José

    Published in Cancer research (Chicago, Ill.) (01-06-2007)
    “…The Fas/FasL system mediates induced apoptosis of immature thymocytes and peripheral T lymphocytes, but little is known about its implication in genetic…”
    Get full text
    Journal Article
  14. 14

    FADD in Cancer: Mechanisms of Altered Expression and Function, and Clinical Implications by Marín-Rubio, José L, Vela-Martín, Laura, Fernández-Piqueras, José, Villa-Morales, María

    Published in Cancers (29-09-2019)
    “…FADD was initially described as an adaptor molecule for death receptor-mediated apoptosis, but subsequently it has been implicated in nonapoptotic cellular…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    EPHA7, a new target gene for 6q deletion in T-cell lymphoblastic lymphomas by López-Nieva, Pilar, Vaquero, Concepción, Fernández-Navarro, Pablo, González-Sánchez, Laura, Villa-Morales, María, Santos, Javier, Esteller, Manel, Fernández-Piqueras, José

    Published in Carcinogenesis (New York) (01-02-2012)
    “…Cryptic deletions at chromosome 6q are common cytogenetic abnormalities in T-cell lymphoblastic leukemia/lymphoma (T-LBL), but the target genes have not been…”
    Get full text
    Journal Article
  18. 18

    The JAK3 Q988P mutation reveals oncogenic potential and resistance to ruxolitinib by Lahera, Antonio, Vela‐Martín, Laura, Fernández‐Navarro, Pablo, Llamas, Pilar, López‐Lorenzo, José L., Cornago, Javier, Santos, Javier, Fernández‐Piqueras, José, VillaMorales, María

    Published in Molecular carcinogenesis (01-01-2024)
    “…Abstract T‐cell acute lymphoblastic leukemia (T‐ALL) arises from the malignant transformation of T‐cell progenitors at various differentiation stages. Given…”
    Get full text
    Journal Article
  19. 19

    Deregulated FADD expression and phosphorylation in T-cell lymphoblastic lymphoma by Marín-Rubio, José L, de Arriba, María C, Cobos-Fernández, María A, González-Sánchez, Laura, Ors, Inmaculada, Sastre, Isabel, Fernández-Piqueras, José, Villa-Morales, María

    Published in Oncotarget (20-09-2016)
    “…In the present work, we show that T-cell lymphoblastic lymphoma cells exhibit a reduction of FADD availability in the cytoplasm, which may contribute to…”
    Get full text
    Journal Article
  20. 20